Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

It may start with mild symptoms and then get worse. Treatment can help symptoms and slow disease progression. Chronic obstructive pulmonary disease, commonly referred to as COPD, is a group of ...

Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people ...

For further information, please contact Professor Dr Felix Ringshausen, [email protected], telephone (0511) 532-3595. The original paper ‘Phase 3 Trial of the DPP1 Inhibitor Brensocatib ...

Dr. Kate Knobil joins the biotech as it looks to combat a viral infection that can be dangerous to patients with the lung ...

IntroductionThe respiratory drugs market refers to the segment of the pharmaceutical industry that deals with drugs designed to treat respiratory disorders, including asthma, chronic obstructive ...

Chronic Obstructive Pulmonary Disease (COPD) Market. COPD market grows with rising disease prevalence, innovation in therapies, and increasing global healt ...

The findings, published in The Lancet Respiratory Medicine, suggest that dupilumab, when used alongside standard triple ...

More people may be at risk for developing COPD due to exposure to environmental irritants, such as heat waves and air ...

Vaayu roga, Dama, Asthma, Saans ki bimari or Eazhai Noi. Though difficulty in breathing can occur due to multiple causes, for ...

A new study published in the journal of Renal Failure showed that patients with chronic obstructive pulmonary disease (COPD) ...